Sino-Argi Leading Biosciences (603970) - Total Liabilities
Based on the latest financial reports, Sino-Argi Leading Biosciences (603970) has total liabilities worth CN¥4.85 Billion CNY (≈ $709.45 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Sino-Argi Leading Biosciences cash flow conversion to assess how effectively this company generates cash.
Sino-Argi Leading Biosciences - Total Liabilities Trend (2012–2024)
This chart illustrates how Sino-Argi Leading Biosciences's total liabilities have evolved over time, based on quarterly financial data. Check Sino-Argi Leading Biosciences (603970) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Sino-Argi Leading Biosciences Competitors by Total Liabilities
The table below lists competitors of Sino-Argi Leading Biosciences ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bank Net Indonesia Syariah Tbk PT
JK:BANK
|
Indonesia | Rp11.13 Trillion |
|
Jiangsu WELLE Environmental Co Ltd
SHE:300190
|
China | CN¥4.41 Billion |
|
Ennis Inc
NYSE:EBF
|
USA | $49.46 Million |
|
Clean Energy Fuels Corp
NASDAQ:CLNE
|
USA | $534.05 Million |
|
Empresa Distribuidora y Comercializadora Norte SA ADR
NYSE:EDN
|
USA | $3.57 Trillion |
|
Bar Harbor Bankshares Inc
NYSE MKT:BHB
|
USA | $4.15 Billion |
|
Bajaj Electricals Limited
NSE:BAJAJELEC
|
India | Rs22.06 Billion |
|
Invesco Quality Municipal Income Closed Fund
NYSE:IQI
|
USA | $297.67 Million |
Liability Composition Analysis (2012–2024)
This chart breaks down Sino-Argi Leading Biosciences's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 603970 market cap overview.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.74 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sino-Argi Leading Biosciences's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sino-Argi Leading Biosciences (2012–2024)
The table below shows the annual total liabilities of Sino-Argi Leading Biosciences from 2012 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.92 Billion ≈ $573.56 Million |
-11.20% |
| 2023-12-31 | CN¥4.41 Billion ≈ $645.92 Million |
-7.26% |
| 2022-12-31 | CN¥4.76 Billion ≈ $696.46 Million |
+37.53% |
| 2021-12-31 | CN¥3.46 Billion ≈ $506.43 Million |
+20.14% |
| 2020-12-31 | CN¥2.88 Billion ≈ $421.52 Million |
+69.95% |
| 2019-12-31 | CN¥1.69 Billion ≈ $248.03 Million |
+4.13% |
| 2018-12-31 | CN¥1.63 Billion ≈ $238.20 Million |
-15.07% |
| 2017-12-31 | CN¥1.92 Billion ≈ $280.45 Million |
-10.86% |
| 2016-12-31 | CN¥2.15 Billion ≈ $314.62 Million |
-0.99% |
| 2015-12-31 | CN¥2.17 Billion ≈ $317.76 Million |
+30.13% |
| 2014-12-31 | CN¥1.67 Billion ≈ $244.19 Million |
+19.92% |
| 2013-12-31 | CN¥1.39 Billion ≈ $203.63 Million |
+40.36% |
| 2012-12-31 | CN¥991.46 Million ≈ $145.08 Million |
-- |
About Sino-Argi Leading Biosciences
Sino-Agri Leading Biosciences Co.,Ltd engages in pesticide distribution in China and internationally. The company sells technical materials, formulations, and related products. It also provides plant protection technology services; and crop health solutions, including technical guidance, application demonstration, and processing and packaging of plant protection products. In addition, the company… Read more